NCT06028646 Dynamic Airway CT is Diagnostic for Tracheomalacia in Children
| NCT ID | NCT06028646 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Tracheomalacia |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2023-08-10 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2023-08-10 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this pilot interventional study is to evaluate the use of Dynamic Airway Computed Tomography (DA-CT) for diagnosis of tracheomalacia in children 0-18 years for whom flexible bronchoscopy has been performed. The primary aims are to evaluate the diagnostic accuracy, image quality, and radiation exposure of DA-CT as a potential noninvasive alternative to the gold standard of flexible bronchoscopy in the diagnosis of tracheomalacia. The results from this pilot study will help to estimate sample size for a larger-scale study with more precise estimates of DA-CT diagnostic potential.
Eligibility Criteria
Inclusion Criteria: * Participants 0-18 years old, with * Clinically indicated flexible bronchoscopy has been performed Exclusion Criteria: * Pregnancy or breastfeeding * Unable to undergo CT scanning without sedation * Patients with tracheostomy
Contact & Investigator
Eleanor Muise, MD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT06028646 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 18 Years, studying Tracheomalacia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06028646 currently recruiting?
Yes, NCT06028646 is actively recruiting participants. Contact the research team at Soumia.Hammouda@nyulangone.org for enrollment information.
Where is the NCT06028646 trial being conducted?
This trial is being conducted at New York, United States, New York, United States.
Who is sponsoring the NCT06028646 clinical trial?
NCT06028646 is sponsored by NYU Langone Health. The principal investigator is Eleanor Muise, MD at NYU Langone Health. The trial plans to enroll 25 participants.